RNA fusions involving are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells.
作者信息
Vallois David, Dupuy Aurélie, Lemonnier Francois, Allen George, Missiaglia Edoardo, Fataccioli Virginie, Ortonne Nicolas, Clavert Aline, Delarue Richard, Rousselet Marie-Christine, Fabiani Bettina, Llamas-Gutierrez Francisco, Ogawa Seishi, Thome Margot, Ko Young Hyeh, Kataoka Keisuke, Gaulard Philippe, de Leval Laurence
机构信息
Institute of Pathology, Lausanne University Hospital, Switzerland.
INSERM U955, Institut Mondor de recherche Biomédicale, Université Paris-Est, Faculté de Médecine, Créteil, France.
出版信息
Haematologica. 2018 Aug;103(8):e360-e363. doi: 10.3324/haematol.2017.186767. Epub 2018 Mar 15.
Abstract
摘要
相似文献
1
RNA fusions involving are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells.涉及的RNA融合在外周T细胞淋巴瘤中很少见，主要集中在那些源自滤泡辅助性T细胞的淋巴瘤中。
Haematologica. 2018 Aug;103(8):e360-e363. doi: 10.3324/haematol.2017.186767. Epub 2018 Mar 15.
2
CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.CD28/CTLA-4/ICOS单倍型赋予Graves病易感性并调节疾病的临床表型。
Endocrine. 2017 Jan;55(1):186-199. doi: 10.1007/s12020-016-1096-1. Epub 2016 Sep 16.
3
Author reply to Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al.作者对Yoo等人《不同类型T细胞淋巴瘤中频繁出现的CTLA4-CD28基因融合》一文评论的回复
Haematologica. 2016 Jun;101(6):e271. doi: 10.3324/haematol.2016.148015. Epub 2016 May 31.
4
Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma.多种类型T细胞淋巴瘤中频繁出现的CTLA4-CD28基因融合。
Haematologica. 2016 Jun;101(6):757-63. doi: 10.3324/haematol.2015.139253. Epub 2016 Jan 27.
5
Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al.对Yoo等人所著《不同类型T细胞淋巴瘤中频繁出现的CTLA4-CD28基因融合》的评论
Haematologica. 2016 Jun;101(6):e269-70. doi: 10.3324/haematol.2016.147074. Epub 2016 May 31.
6
Recurrent activating mutations of CD28 in peripheral T-cell lymphomas.外周T细胞淋巴瘤中CD28的复发性激活突变。
Leukemia. 2016 May;30(5):1062-70. doi: 10.1038/leu.2015.357. Epub 2015 Dec 31.
7
The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.诱导型 T 细胞共刺激分子表达于 T 细胞亚群上，是滤泡辅助性 T 细胞来源的淋巴瘤的一个新的标志物。
Haematologica. 2010 Mar;95(3):432-9. doi: 10.3324/haematol.2009.010991.
8
Altered expression of CTLA-4, CD28, VDR, and CD45 mRNA in T cells of patients with Hashimoto's thyroiditis - a pilot study.桥本甲状腺炎患者T细胞中CTLA-4、CD28、VDR和CD45 mRNA表达的改变——一项初步研究。
Endokrynol Pol. 2017;68(3):274-828. doi: 10.5603/EP.2017.0020.
9
Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions.年轻的急性 T 淋巴细胞白血病患者的基因组特征揭示了频繁可靶向的 CD28 融合。
Blood. 2020 Apr 23;135(17):1467-1471. doi: 10.1182/blood.2019001815.
10
Chromosome 2q33genetic polymorphisms in Tunisian endemic pemphigus foliaceus.染色体 2q33 遗传多态性与突尼斯地方性落叶型天疱疮。
Mol Genet Genomic Med. 2020 Nov;8(11):e1476. doi: 10.1002/mgg3.1476. Epub 2020 Sep 1.
引用本文的文献
1
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma.综合基因组和转录组分析揭示血管免疫母细胞性T细胞淋巴瘤中可靶向的脆弱性。
Am J Hematol. 2025 Sep;100(9):1486-1501. doi: 10.1002/ajh.27736. Epub 2025 Jun 13.
2
Biological and Clinical Relevance of Genetic Alterations in Peripheral T-cell Lymphomas.外周T细胞淋巴瘤基因改变的生物学及临床相关性
JMA J. 2025 Apr 28;8(2):345-353. doi: 10.31662/jmaj.2024-0405. Epub 2025 Mar 7.
3
A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities.一个患者来源的T细胞淋巴瘤生物样本库揭示了致病机制和宿主相关的治疗弱点。
Cell Rep Med. 2025 Apr 15;6(4):102029. doi: 10.1016/j.xcrm.2025.102029. Epub 2025 Mar 26.
4
Binding of RHOA G17V to p300 enhances its HAT activity: a new mechanism of epigenetic deregulation in TFH lymphoma.RHOA G17V与p300的结合增强其组蛋白乙酰转移酶活性：滤泡辅助性T细胞淋巴瘤表观遗传失调的新机制。
Blood Adv. 2025 Jun 24;9(12):3031-3043. doi: 10.1182/bloodadvances.2024014671.
5
Advances in peripheral T cell lymphomas: pathogenesis, genetic landscapes and emerging therapeutic targets.外周T细胞淋巴瘤的进展：发病机制、基因图谱及新兴治疗靶点
Histopathology. 2025 Jan;86(1):119-133. doi: 10.1111/his.15376.
6
New insights into the biology of T-cell lymphomas.T 细胞淋巴瘤生物学的新见解。
Blood. 2024 Oct 31;144(18):1873-1886. doi: 10.1182/blood.2023021787.
7
Therapeutic challenges in peripheral T-cell lymphoma.外周 T 细胞淋巴瘤的治疗挑战。
Mol Cancer. 2024 Jan 4;23(1):2. doi: 10.1186/s12943-023-01904-w.
8
Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions.结外周 T 细胞淋巴瘤的病理生物学：当前认识与未来方向。
Haematologica. 2023 Dec 1;108(12):3227-3243. doi: 10.3324/haematol.2023.282716.
9
Co-stimulatory and immune checkpoint molecules are important in the tumor microenvironment of Hodgkin-like adult T-cell leukemia/lymphoma.共刺激分子和免疫检查点分子在霍奇金样成人T细胞白血病/淋巴瘤的肿瘤微环境中起重要作用。
Haematologica. 2023 Dec 1;108(12):3496-3501. doi: 10.3324/haematol.2023.283163.
10
How molecular advances may improve the diagnosis and management of PTCL patients.分子学进展如何改善外周T细胞淋巴瘤（PTCL）患者的诊断与管理。
Front Oncol. 2023 Jun 23;13:1202964. doi: 10.3389/fonc.2023.1202964. eCollection 2023.
本文引用的文献
1
Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin.血管免疫母细胞性T细胞淋巴瘤及其他滤泡辅助性T细胞起源的淋巴结淋巴瘤的综合临床病理与分子分析
Haematologica. 2017 Apr;102(4):e148-e151. doi: 10.3324/haematol.2016.158428. Epub 2017 Jan 12.
2
Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.在血管免疫母细胞性和其他滤泡辅助 T 细胞来源的淋巴瘤中，与 TCR 信号相关的基因中的激活突变。
Blood. 2016 Sep 15;128(11):1490-502. doi: 10.1182/blood-2016-02-698977. Epub 2016 Jul 1.
3
Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al.对Yoo等人所著《不同类型T细胞淋巴瘤中频繁出现的CTLA4-CD28基因融合》的评论
Haematologica. 2016 Jun;101(6):e269-70. doi: 10.3324/haematol.2016.147074. Epub 2016 May 31.
4
Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma.多种类型T细胞淋巴瘤中频繁出现的CTLA4-CD28基因融合。
Haematologica. 2016 Jun;101(6):757-63. doi: 10.3324/haematol.2015.139253. Epub 2016 Jan 27.
5
Recurrent activating mutations of CD28 in peripheral T-cell lymphomas.外周T细胞淋巴瘤中CD28的复发性激活突变。
Leukemia. 2016 May;30(5):1062-70. doi: 10.1038/leu.2015.357. Epub 2015 Dec 31.
6
Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes.覃样肉芽肿的基因组分析确定关键T细胞信号传导和分化基因的改变。
Nat Genet. 2015 Dec;47(12):1426-34. doi: 10.1038/ng.3444. Epub 2015 Nov 9.
7
Integrated molecular analysis of adult T cell leukemia/lymphoma.成人 T 细胞白血病/淋巴瘤的综合分子分析。
Nat Genet. 2015 Nov;47(11):1304-15. doi: 10.1038/ng.3415. Epub 2015 Oct 5.
8
Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2.蕈样肉芽肿和 Sézary 综合征的基因组分析确定了 TNFR2 中的复发性改变。
Nat Genet. 2015 Sep;47(9):1056-60. doi: 10.1038/ng.3370. Epub 2015 Aug 10.
9
Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets.血管免疫母细胞性T细胞淋巴瘤是两个不同的法国信息数据集中最常见的T细胞淋巴瘤。
Haematologica. 2015 Sep;100(9):e361-4. doi: 10.3324/haematol.2015.126300. Epub 2015 Jun 4.
10
Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.通过靶向新型 CTLA4:CD28 融合蛋白对 Sézary 综合征进行个体化治疗。
Mol Genet Genomic Med. 2015 Mar;3(2):130-6. doi: 10.1002/mgg3.121. Epub 2014 Nov 27.
Zotero 插件